Elsevier

Brain Research

Volume 194, Issue 1, 21 July 1980, Pages 117-124
Brain Research

Influence of dopaminergic systems on the lateral habenular nucleus of the rat

https://doi.org/10.1016/0006-8993(80)91322-0Get rights and content

Abstract

The alterations in glucose utilization in the lateral habenular nucleus following the systemic administration of a putative dopaminergic agonist and antagonist have been examined in 48 rats by means of the autoradiographic 2-deoxyglycose technique. The administration of apomorphine (0.15–5 mg/kg) resulted in significant dose-dependent reductions (by25 ± 5% following 0.5 mg/kg) in glucose utilization in the lateral habenula. Haloperidol administration (0.01–10 mg/kg) was associated with increased (by46 ± 17% with 0.1 mg/kg) glucose utilization in the lateral habenula. The effects of apomorphine upon metabolic activity in the lateral habenula can be prevented by the prior administration of haloperidol (0.1 mg/kg).

These observations provide evidence that metabolic activity in the lateral habenula, a nucleus occupying a strategic position between the forebrain and the mesencephalon, may be regulated by the activity in dopaminergic systems.

Reference (20)

There are more references available in the full text version of this article.

Cited by (72)

  • The dorsal diencephalic conduction system in reward processing: Spotlight on the anatomy and functions of the habenular complex

    2018, Behavioural Brain Research
    Citation Excerpt :

    The view that the LHb receives direct inputs from midbrain dopaminergic nuclei [66,102], together with evidence showing that it expresses DA D2 and D4 receptors [32,45], suggest that its activity is most likely influenced by changes in DA transmission. Findings in support of this hypothesis come from metabolic studies showing that DA receptor agonists and DA-increasing drugs decrease LHb glucose consumption [103–105], in contrast to DA receptor antagonists, which increase LHb glucose consumption [104,106]. Although these studies suggest a negative correlation between the functional activity of the LHb and the DA system, the relationship between midbrain DA and LHb neurons appears to be far more complex.

  • A Unique Population of Ventral Tegmental Area Neurons Inhibits the Lateral Habenula to Promote Reward

    2013, Neuron
    Citation Excerpt :

    Additionally, because TH is produced in the soma, THVTA-LHb neurons may be releasing dopamine locally from the somatodendritic compartment, which could then activate D2 autoreceptors to modulate the firing rate of neighboring VTA neurons (Adell and Artigas, 2004). Previous studies have found that systemic injections of dopaminergic agonists and bath-application of high concentrations of dopamine result in changes in the firing patterns and glucose utilization of LHb neurons (Jhou et al., 2013; Kowski et al., 2009; McCulloch et al., 1980). However, as dopaminergic agonists often have affinities for serotonin receptors (Newman-Tancredi et al., 2002), which are thought to reside on presynaptic terminals in the LHb (Shabel et al., 2012), it is unclear whether the effects of these agonists on LHb activity arise from direct activation of dopamine receptors in the LHb.

  • Differential contribution of mesoaccumbens and mesohabenular dopamine to intracranial self-stimulation

    2013, Neuropharmacology
    Citation Excerpt :

    Our findings highlight the differential contribution of mesoaccumbens and mesohabenular DA to reward and performance. The lack of effect with LHb infusions was somewhat surprising given that a number of studies have shown that habenular metabolic activity is highly sensitive to changes in DA transmission (McCulloch et al., 1980; Wechsler et al., 1979). More particularly for our purposes, brain stimulation reward or DA agonists such as amphetamine reduce metabolic demand whereas DA antagonists in doses that attenuate rewarding effectiveness enhance LHb metabolic activity (Gallistel et al., 1985; Gomita and Gallistel, 1982).

View all citing articles on Scopus
*

Present address: Wellcome Surgical Institute, University of Glasgow, Glasgow, U.K.

**

Fogarty International Post-Doctoral Fellow.

View full text